Company intelligence / Profile preview

Sleep.ai

Nijmegen, Gelderland, The Netherlandssleep.ai ↗

Ownership: Private
Development stage: Commercial

Overview

The company developed validated apps and wearables for snoring/bruxism detection, with scientific backing including randomized controlled trials. Its technology became the first digital sleep improvement solution reimbursed by law in Germany. After acquisition by SleepScore Labs, its core technologies power the broader "Sleep.AI" intelligence platform used commercially by health/wellness brands.

Therapeutic areas: PulmonologyNeurology
Modalities: DeviceDigital therapeuticNon-pharmacological therapy
Industry: Digital Health Medical Devices

Partnerships

TherabodyMattress FirmHuman Longevity Inc.

Beyond the preview

Go deeper on Sleep.ai.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sleep.ai.

Explore the full profile